Thomas Gad is CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 181,531 shares of YMAB, which is worth approximately $2.7 Million. The most recent transaction as insider was on Sep 19, 2024, when has been sold 22,831 shares (Common Stock) at a price of $4.38 per share, resulting in proceeds of $99,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K
14.39% 3M change
100.59% 12M change
Total Value Held $2.7 Million

Thomas Gad Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 19 2024
BUY
Exercise of conversion of derivative security
$99,999 $4.38 p/Share
22,831 Added 11.17%
181,531 Common Stock
Mar 05 2024
SELL
Open market or private sale
$64,116 $16.44 p/Share
3,900 Reduced 2.4%
158,700 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
22,100 Added 11.97%
162,600 Common Stock
Dec 21 2023
BUY
Exercise of conversion of derivative security
$100,000 $2.0 p/Share
50,000 Added 26.25%
140,500 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
40,500 Added 30.92%
90,500 Common Stock
Feb 01 2022
SELL
Open market or private sale
$81,200 $10.15 p/Share
8,000 Reduced 13.79%
50,000 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
$16,000 $2.0 p/Share
8,000 Added 12.12%
58,000 Common Stock
Jan 18 2022
SELL
Open market or private sale
$92,320 $11.54 p/Share
8,000 Reduced 13.79%
50,000 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
$16,000 $2.0 p/Share
8,000 Added 12.12%
58,000 Common Stock
Nov 23 2021
SELL
Open market or private sale
$853,000 $17.06 p/Share
50,000 Reduced 50.0%
50,000 Common Stock
Nov 23 2021
BUY
Exercise of conversion of derivative security
$100,000 $2.0 p/Share
50,000 Added 33.33%
100,000 Common Stock
Sep 07 2021
BUY
Exercise of conversion of derivative security
$100,000 $2.0 p/Share
50,000 Added 50.0%
50,000 Common Stock
Apr 26 2021
SELL
Open market or private sale
$195,720 $27.96 p/Share
7,000 Reduced 100.0%
0 Common Stock
Apr 26 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Apr 12 2021
SELL
Open market or private sale
$186,270 $26.61 p/Share
7,000 Reduced 100.0%
0 Common Stock
Apr 12 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Apr 01 2021
SELL
Open market or private sale
$272,340 $30.26 p/Share
9,000 Reduced 100.0%
0 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$18,000 $2.0 p/Share
9,000 Added 50.0%
9,000 Common Stock
Mar 15 2021
SELL
Open market or private sale
$257,530 $36.79 p/Share
7,000 Reduced 100.0%
0 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Mar 01 2021
SELL
Open market or private sale
$319,590 $35.51 p/Share
9,000 Reduced 100.0%
0 Common Stock
Mar 01 2021
BUY
Exercise of conversion of derivative security
$18,000 $2.0 p/Share
9,000 Added 50.0%
9,000 Common Stock
Feb 16 2021
SELL
Open market or private sale
$329,560 $47.08 p/Share
7,000 Reduced 100.0%
0 Common Stock
Feb 16 2021
BUY
Exercise of conversion of derivative security
$14,000 $2.0 p/Share
7,000 Added 50.0%
7,000 Common Stock
Feb 01 2021
SELL
Open market or private sale
$293,930 $41.99 p/Share
7,000 Reduced 100.0%
0 Common Stock
TG

Thomas Gad

CHIEF BUSINESS OFFICER
New York, NY

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB